Biocompatibility and fibrous response of polymethylmethacrylate in skeletal muscles
International Journal of Development Research
Biocompatibility and fibrous response of polymethylmethacrylate in skeletal muscles
Received 03rd August, 2021; Received in revised form 19th September, 2021; Accepted 17th October, 2021; Published online 30th October, 2021
Copyright © 2021, Eduardo da Costa Teixeira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Polymethylmethacrylate (PMMA) is a synthetic polymer produced in microspheres form, used in many biomedical areas. Objective: To determine the PMMA injections biocompatibility in striated muscle tissue of Wistar rats. Methods: In vivo biocompatibility and fibrous tissue healing were assessed by histopathological evaluation at 2, 4, 8, and 16 weeks after implantation in 3 groups of adult rats. Group 1, with 20 adult rats, was injected with 30% PMMA gel in the ventral muscle. Other two groups with 20 and 5 rats were studied as control subjects. Group 2 was injected with the same amount of saline solution in the ventral muscle, while the subjects in group 3 underwent anesthesia and surgical incision. Results: After two weeks, a histiocytic inflammatory response was observed in group 1. The capsule formation where type I collagen predominated and a septum between the spheres, rich in collagen type III, which resulted in a stable foreign-body granuloma. No evidence of lymphocytic local reaction, tissue suffering, or necrosis was observed. Conclusion: PMMA is biocompatible when injected into the striated muscle tissue of Wistar rats. There was a fibrous response induced by PMMA showing microspheres surrounded by stable histiocytic granuloma without evidence of toxic or antigenic activities.